Aadi Bioscience, Inc.

NASDAQ (USD): Aadi Bioscience, Inc. (AADI)

Last Price

2.32

Today's Change

+0.03 (1.31%)

Day's Change

2.27 - 2.34

Trading Volume

77,313

Overview

Market Cap

57 Million

Shares Outstanding

24 Million

Avg Volume

113,349

Avg Price (50 Days)

2.19

Avg Price (200 Days)

1.89

PE Ratio

-1.02

EPS

-2.28

Earnings Announcement

11-Mar-2025

Previous Close

2.29

Open

2.34

Day's Range

2.27 - 2.34

Year Range

1.21 - 2.626

Trading Volume

77,035

Price Change Highlight

1 Day Change

1.31%

5 Day Change

-4.13%

1 Month Change

4.50%

3 Month Change

20.21%

6 Month Change

42.33%

Ytd Change

13.17%

1 Year Change

12.62%

3 Year Change

-91.01%

5 Year Change

-72.58%

10 Year Change

-97.42%

Max Change

-97.42%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment